Ciprofloxacin-resistant campylobacteriosis in the UK

By contrast, the levels of erythromycin resistance have remained unchanged at under 2.5%. Since ciprofloxacin can no longer be safely assumed to be an effective treatment, routine laboratory suscept ibility testing of isolates is essential.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2010-12, Vol.376 (9757), p.1987-1987
Hauptverfasser:	Cody, Alison J, Clarke, Lorraine, Bowler, Ian CJW, Dingle, Kate E
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - pharmacology Bacteria Campylobacter - drug effects Campylobacter - isolation & purification Campylobacter Infections - drug therapy Campylobacter Infections - epidemiology Campylobacter Infections - prevention & control Campylobacter Infections - veterinary Ciprofloxacin - administration & dosage Ciprofloxacin - pharmacology Drug Resistance, Bacterial Fluoroquinolones - administration & dosage Humans Incidence Internal Medicine Poultry Poultry Diseases - prevention & control United Kingdom - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	By contrast, the levels of erythromycin resistance have remained unchanged at under 2.5%. Since ciprofloxacin can no longer be safely assumed to be an effective treatment, routine laboratory suscept ibility testing of isolates is essential.
ISSN:	0140-6736 1474-547X
DOI:	10.1016/S0140-6736(10)62261-1